1. Meng, Qingliang, Wei, Kai, Shan, Yu. 2024. E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes. In Frontiers in immunology, 15, 1433898. doi:10.3389/fimmu.2024.1433898. https://pubmed.ncbi.nlm.nih.gov/39301019/
2. Lee, Min Kyeong, Noh, Joo Kyung, Woo, Seon Rang, Ko, Seong-Gyu, Eun, Young-Gyu. . Prognostic Significance of the BIRC2-BIRC3 Gene Signature in Head and Neck Squamous Cell Carcinoma. In Cancer genomics & proteomics, 19, 591-605. doi:10.21873/cgp.20344. https://pubmed.ncbi.nlm.nih.gov/35985688/
3. Kan, Mengyuan, Diwadkar, Avantika R, Shuai, Haoyue, Wu, Ann Chen, Himes, Blanca E. 2021. Multiomics analysis identifies BIRC3 as a novel glucocorticoid response-associated gene. In The Journal of allergy and clinical immunology, 149, 1981-1991. doi:10.1016/j.jaci.2021.11.025. https://pubmed.ncbi.nlm.nih.gov/34971648/
4. Mansouri, Larry, Thorvaldsdottir, Birna, Sutton, Lesley-Ann, Stamatopoulos, Kostas, Rosenquist, Richard. 2022. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. In Leukemia, 37, 339-347. doi:10.1038/s41375-022-01802-y. https://pubmed.ncbi.nlm.nih.gov/36566271/
5. Nadeu, Ferran, Delgado, Julio, Royo, Cristina, Enjuanes, Anna, Campo, Elías. 2016. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. In Blood, 127, 2122-30. doi:10.1182/blood-2015-07-659144. https://pubmed.ncbi.nlm.nih.gov/26837699/
6. Jain, Preetesh, Wang, Michael. 2019. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. In American journal of hematology, 94, 710-725. doi:10.1002/ajh.25487. https://pubmed.ncbi.nlm.nih.gov/30963600/
智鼠故事 
